APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aurora Kinase C

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Aurora Kinase C Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchAurora Kinase C Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Aurora Kinase C Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Aurora Kinase C Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aurora Kinase C Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Aurora Kinase C Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Aurora Kinase C market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Aurora Kinase C is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Aurora Kinase C is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Aurora Kinase C is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Aurora Kinase C is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Aurora Kinase C include Sanofi, Amgen Inc, AbbVie Inc and Cielo Therapeutics Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Aurora Kinase C, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Aurora Kinase C, also provides the sales of main regions and countries. Of the upcoming market potential for Aurora Kinase C, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Aurora Kinase C sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Aurora Kinase C market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Aurora Kinase C sales, projected growth trends, production technology, application and end-user industry.

Aurora Kinase C Segment by Company

Sanofi

Amgen Inc

AbbVie Inc

Cielo Therapeutics Inc

Aurora Kinase C Segment by Type

AMG-900

Ilorasertib

NMI-900

SAR-156497

Danusertib

Others

Aurora Kinase C Segment by Application

Non-Small Cell Lung Cancer

Acute Lymphocytic Leukemia

Solid Tumor

Others

Aurora Kinase C Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase C market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase C and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase C.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Aurora Kinase C in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Aurora Kinase C manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aurora Kinase C sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Aurora Kinase C Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. AMG-900 Major Manufacturers Table 3. Ilorasertib Major Manufacturers Table 4. NMI-900 Major Manufacturers Table 5. SAR-156497 Major Manufacturers Table 6. Danusertib Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Aurora Kinase C Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Non-Small Cell Lung Cancer Major Manufacturers Table 10. Acute Lymphocytic Leukemia Major Manufacturers Table 11. Solid Tumor Major Manufacturers Table 12. Others Major Manufacturers Table 13. Aurora Kinase C Industry Trends Table 14. Aurora Kinase C Industry Drivers Table 15. Aurora Kinase C Industry Opportunities and Challenges Table 16. Aurora Kinase C Industry Restraints Table 17. Global Aurora Kinase C Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Aurora Kinase C Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Aurora Kinase C Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Aurora Kinase C Revenue Market Share by Region (2021-2026) Table 21. Global Aurora Kinase C Revenue Market Share by Region (2027-2032) Table 22. Global Aurora Kinase C Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 23. Global Aurora Kinase C Sales by Region (2021-2026) & (k units) Table 24. Global Aurora Kinase C Sales by Region (2027-2032) & (k units) Table 25. Global Aurora Kinase C Sales Market Share by Region (2021-2026) Table 26. Global Aurora Kinase C Sales Market Share by Region (2027-2032) Table 27. Global Aurora Kinase C Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Aurora Kinase C Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Aurora Kinase C Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Aurora Kinase C Sales Market Share by Manufacturers (2021-2026) Table 31. Global Aurora Kinase C Sales Price (US$/unit) of Manufacturers (2021-2026) Table 32. Global Aurora Kinase C Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Aurora Kinase C Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Aurora Kinase C Manufacturers, Product Type & Application Table 35. Global Aurora Kinase C Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Aurora Kinase C by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Aurora Kinase C Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Aurora Kinase C Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Aurora Kinase C Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Aurora Kinase C Revenue Market Share by Type (2021-2026) Table 42. Global Aurora Kinase C Revenue Market Share by Type (2027-2032) Table 43. Global Aurora Kinase C Sales by Type 2021 VS 2025 VS 2032 (k units) Table 44. Global Aurora Kinase C Sales by Type (2021-2026) & (k units) Table 45. Global Aurora Kinase C Sales by Type (2027-2032) & (k units) Table 46. Global Aurora Kinase C Sales Market Share by Type (2021-2026) Table 47. Global Aurora Kinase C Sales Market Share by Type (2027-2032) Table 48. Global Aurora Kinase C Price by Type (2021-2026) & (US$/unit) Table 49. Global Aurora Kinase C Price by Type (2027-2032) & (US$/unit) Table 50. Global Aurora Kinase C Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Aurora Kinase C Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Aurora Kinase C Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Aurora Kinase C Revenue Market Share by Application (2021-2026) Table 54. Global Aurora Kinase C Revenue Market Share by Application (2027-2032) Table 55. Global Aurora Kinase C Sales by Application 2021 VS 2025 VS 2032 (k units) Table 56. Global Aurora Kinase C Sales by Application (2021-2026) & (k units) Table 57. Global Aurora Kinase C Sales by Application (2027-2032) & (k units) Table 58. Global Aurora Kinase C Sales Market Share by Application (2021-2026) Table 59. Global Aurora Kinase C Sales Market Share by Application (2027-2032) Table 60. Global Aurora Kinase C Price by Application (2021-2026) & (US$/unit) Table 61. Global Aurora Kinase C Price by Application (2027-2032) & (US$/unit) Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Aurora Kinase C Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Sanofi Aurora Kinase C Product Portfolio Table 66. Sanofi Recent Development Table 67. Amgen Inc Company Information Table 68. Amgen Inc Business Overview Table 69. Amgen Inc Aurora Kinase C Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Amgen Inc Aurora Kinase C Product Portfolio Table 71. Amgen Inc Recent Development Table 72. AbbVie Inc Company Information Table 73. AbbVie Inc Business Overview Table 74. AbbVie Inc Aurora Kinase C Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. AbbVie Inc Aurora Kinase C Product Portfolio Table 76. AbbVie Inc Recent Development Table 77. Cielo Therapeutics Inc Company Information Table 78. Cielo Therapeutics Inc Business Overview Table 79. Cielo Therapeutics Inc Aurora Kinase C Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Cielo Therapeutics Inc Aurora Kinase C Product Portfolio Table 81. Cielo Therapeutics Inc Recent Development Table 82. North America Aurora Kinase C Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Aurora Kinase C Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Aurora Kinase C Sales by Type (2021-2026) & (k units) Table 85. North America Aurora Kinase C Sales by Type (2027-2032) & (k units) Table 86. North America Aurora Kinase C Sales Price by Type (2021-2026) & (US$/unit) Table 87. North America Aurora Kinase C Sales Price by Type (2027-2032) & (US$/unit) Table 88. North America Aurora Kinase C Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Aurora Kinase C Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Aurora Kinase C Sales by Application (2021-2026) & (k units) Table 91. North America Aurora Kinase C Sales by Application (2027-2032) & (k units) Table 92. North America Aurora Kinase C Sales Price by Application (2021-2026) & (US$/unit) Table 93. North America Aurora Kinase C Sales Price by Application (2027-2032) & (US$/unit) Table 94. North America Aurora Kinase C Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Aurora Kinase C Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Aurora Kinase C Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Aurora Kinase C Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 98. North America Aurora Kinase C Sales by Country (2021-2026) & (k units) Table 99. North America Aurora Kinase C Sales by Country (2027-2032) & (k units) Table 100. North America Aurora Kinase C Sales Price by Country (2021-2026) & (US$/unit) Table 101. North America Aurora Kinase C Sales Price by Country (2027-2032) & (US$/unit) Table 102. United States Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 103. Canada Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 104. Mexico Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 105. Europe Aurora Kinase C Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Aurora Kinase C Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Aurora Kinase C Sales by Type (2021-2026) & (k units) Table 108. Europe Aurora Kinase C Sales by Type (2027-2032) & (k units) Table 109. Europe Aurora Kinase C Sales Price by Type (2021-2026) & (US$/unit) Table 110. Europe Aurora Kinase C Sales Price by Type (2027-2032) & (US$/unit) Table 111. Europe Aurora Kinase C Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Aurora Kinase C Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Aurora Kinase C Sales by Application (2021-2026) & (k units) Table 114. Europe Aurora Kinase C Sales by Application (2027-2032) & (k units) Table 115. Europe Aurora Kinase C Sales Price by Application (2021-2026) & (US$/unit) Table 116. Europe Aurora Kinase C Sales Price by Application (2027-2032) & (US$/unit) Table 117. Europe Aurora Kinase C Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Aurora Kinase C Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Aurora Kinase C Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Aurora Kinase C Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 121. Europe Aurora Kinase C Sales by Country (2021-2026) & (k units) Table 122. Europe Aurora Kinase C Sales by Country (2027-2032) & (k units) Table 123. Europe Aurora Kinase C Sales Price by Country (2021-2026) & (US$/unit) Table 124. Europe Aurora Kinase C Sales Price by Country (2027-2032) & (US$/unit) Table 125. Germany Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 126. France Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 127. U.K. Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 128. Italy Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 129. Russia Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 130. Spain Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 133. Sweden Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 134. Poland Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 135. China Aurora Kinase C Revenue by Type (2021-2026) & (US$ Million) Table 136. China Aurora Kinase C Revenue by Type (2027-2032) & (US$ Million) Table 137. China Aurora Kinase C Sales by Type (2021-2026) & (k units) Table 138. China Aurora Kinase C Sales by Type (2027-2032) & (k units) Table 139. China Aurora Kinase C Sales Price by Type (2021-2026) & (US$/unit) Table 140. China Aurora Kinase C Sales Price by Type (2027-2032) & (US$/unit) Table 141. China Aurora Kinase C Revenue by Application (2021-2026) & (US$ Million) Table 142. China Aurora Kinase C Revenue by Application (2027-2032) & (US$ Million) Table 143. China Aurora Kinase C Sales by Application (2021-2026) & (k units) Table 144. China Aurora Kinase C Sales by Application (2027-2032) & (k units) Table 145. China Aurora Kinase C Sales Price by Application (2021-2026) & (US$/unit) Table 146. China Aurora Kinase C Sales Price by Application (2027-2032) & (US$/unit) Table 147. Asia Aurora Kinase C Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Aurora Kinase C Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Aurora Kinase C Sales by Type (2021-2026) & (k units) Table 150. Asia Aurora Kinase C Sales by Type (2027-2032) & (k units) Table 151. Asia Aurora Kinase C Sales Price by Type (2021-2026) & (US$/unit) Table 152. Asia Aurora Kinase C Sales Price by Type (2027-2032) & (US$/unit) Table 153. Asia Aurora Kinase C Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Aurora Kinase C Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Aurora Kinase C Sales by Application (2021-2026) & (k units) Table 156. Asia Aurora Kinase C Sales by Application (2027-2032) & (k units) Table 157. Asia Aurora Kinase C Sales Price by Application (2021-2026) & (US$/unit) Table 158. Asia Aurora Kinase C Sales Price by Application (2027-2032) & (US$/unit) Table 159. Asia Aurora Kinase C Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Aurora Kinase C Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Aurora Kinase C Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Aurora Kinase C Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. Asia Aurora Kinase C Sales by Country (2021-2026) & (k units) Table 164. Asia Aurora Kinase C Sales by Country (2027-2032) & (k units) Table 165. Asia Aurora Kinase C Sales Price by Country (2021-2026) & (US$/unit) Table 166. Asia Aurora Kinase C Sales Price by Country (2027-2032) & (US$/unit) Table 167. Japan Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 168. South Korea Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 169. India Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 170. Australia Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Aurora Kinase C Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Aurora Kinase C Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Aurora Kinase C Sales by Type (2021-2026) & (k units) Table 176. SAMEA Aurora Kinase C Sales by Type (2027-2032) & (k units) Table 177. SAMEA Aurora Kinase C Sales Price by Type (2021-2026) & (US$/unit) Table 178. SAMEA Aurora Kinase C Sales Price by Type (2027-2032) & (US$/unit) Table 179. SAMEA Aurora Kinase C Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Aurora Kinase C Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Aurora Kinase C Sales by Application (2021-2026) & (k units) Table 182. SAMEA Aurora Kinase C Sales by Application (2027-2032) & (k units) Table 183. SAMEA Aurora Kinase C Sales Price by Application (2021-2026) & (US$/unit) Table 184. SAMEA Aurora Kinase C Sales Price by Application (2027-2032) & (US$/unit) Table 185. SAMEA Aurora Kinase C Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Aurora Kinase C Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Aurora Kinase C Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Aurora Kinase C Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. SAMEA Aurora Kinase C Sales by Country (2021-2026) & (k units) Table 190. SAMEA Aurora Kinase C Sales by Country (2027-2032) & (k units) Table 191. SAMEA Aurora Kinase C Sales Price by Country (2021-2026) & (US$/unit) Table 192. SAMEA Aurora Kinase C Sales Price by Country (2027-2032) & (US$/unit) Table 193. Brazil Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 194. Argentina Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 195. Chile Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 196. Colombia Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 197. Peru Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 199. Israel Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 200. UAE Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 201. Turkey Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 202. Iran Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 203. Egypt Aurora Kinase C Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Aurora Kinase C Distributors List Table 207. Aurora Kinase C Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Aurora Kinase C Image Figure 2. Global Aurora Kinase C Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aurora Kinase C Market Size Share 2021 VS 2025 VS 2032 Figure 4. AMG-900 Image Figure 5. Ilorasertib Image Figure 6. NMI-900 Image Figure 7. SAR-156497 Image Figure 8. Danusertib Image Figure 9. Others Image Figure 10. Global Aurora Kinase C Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Aurora Kinase C Market Size Share 2021 VS 2025 VS 2032 Figure 12. Non-Small Cell Lung Cancer Image Figure 13. Acute Lymphocytic Leukemia Image Figure 14. Solid Tumor Image Figure 15. Others Image Figure 16. Global Aurora Kinase C Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Aurora Kinase C Revenue (2021-2032) & (US$ Million) Figure 18. Global Aurora Kinase C Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Aurora Kinase C Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Aurora Kinase C Revenue Market Share by Region (2021-2032) Figure 21. Global Aurora Kinase C Sales (2021-2032) & (k units) Figure 22. Global Aurora Kinase C Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Aurora Kinase C Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Aurora Kinase C Sales YoY (2021-2032) & (k units) Figure 25. Europe Aurora Kinase C Sales YoY (2021-2032) & (k units) Figure 26. China Aurora Kinase C Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Aurora Kinase C Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Aurora Kinase C Sales YoY (2021-2032) & (k units) Figure 29. Global Aurora Kinase C Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Aurora Kinase C Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Aurora Kinase C Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Aurora Kinase C Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Aurora Kinase C Revenue Market Share by Type (2021-2032) Figure 35. Global Aurora Kinase C Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Aurora Kinase C Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Aurora Kinase C Sales Market Share by Type (2021-2032) Figure 38. Global Aurora Kinase C Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Aurora Kinase C Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Aurora Kinase C Revenue Market Share by Application (2021-2032) Figure 41. Global Aurora Kinase C Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 42. Global Aurora Kinase C Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Aurora Kinase C Sales Market Share by Application (2021-2032) Figure 44. North America Aurora Kinase C Revenue Share by Type (2021-2032) Figure 45. North America Aurora Kinase C Sales Share by Type (2021-2032) Figure 46. North America Aurora Kinase C Revenue Share by Application (2021-2032) Figure 47. North America Aurora Kinase C Sales Share by Application (2021-2032) Figure 48. North America Aurora Kinase C Revenue Share by Country (2021-2032) Figure 49. North America Aurora Kinase C Sales Share by Country (2021-2032) Figure 50. Europe Aurora Kinase C Revenue Share by Type (2021-2032) Figure 51. Europe Aurora Kinase C Sales Share by Type (2021-2032) Figure 52. Europe Aurora Kinase C Revenue Share by Application (2021-2032) Figure 53. Europe Aurora Kinase C Sales Share by Application (2021-2032) Figure 54. Europe Aurora Kinase C Revenue Share by Country (2021-2032) Figure 55. Europe Aurora Kinase C Sales Share by Country (2021-2032) Figure 56. China Aurora Kinase C Revenue Share by Type (2021-2032) Figure 57. China Aurora Kinase C Sales Share by Type (2021-2032) Figure 58. China Aurora Kinase C Revenue Share by Application (2021-2032) Figure 59. China Aurora Kinase C Sales Share by Application (2021-2032) Figure 60. Asia Aurora Kinase C Revenue Share by Type (2021-2032) Figure 61. Asia Aurora Kinase C Sales Share by Type (2021-2032) Figure 62. Asia Aurora Kinase C Revenue Share by Application (2021-2032) Figure 63. Asia Aurora Kinase C Sales Share by Application (2021-2032) Figure 64. Asia Aurora Kinase C Revenue Share by Country (2021-2032) Figure 65. Asia Aurora Kinase C Sales Share by Country (2021-2032) Figure 66. SAMEA Aurora Kinase C Revenue Share by Type (2021-2032) Figure 67. SAMEA Aurora Kinase C Sales Share by Type (2021-2032) Figure 68. SAMEA Aurora Kinase C Revenue Share by Application (2021-2032) Figure 69. SAMEA Aurora Kinase C Sales Share by Application (2021-2032) Figure 70. SAMEA Aurora Kinase C Revenue Share by Country (2021-2032) Figure 71. SAMEA Aurora Kinase C Sales Share by Country (2021-2032) Figure 72. Aurora Kinase C Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Aurora Kinase C Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • AMG-900
  • Ilorasertib
  • NMI-900
  • SAR-156497
  • Danusertib
  • Others
Applications
  • Non-Small Cell Lung Cancer
  • Acute Lymphocytic Leukemia
  • Solid Tumor
  • Others
Companies covered
  • Sanofi
  • Amgen Inc
  • AbbVie Inc
  • Cielo Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Aurora Kinase C Market by Type
  3. 1.2.1 Global Aurora Kinase C Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 AMG-900
  5. 1.2.3 Ilorasertib
  6. 1.2.4 NMI-900
  7. 1.2.5 SAR-156497
  8. 1.2.6 Danusertib
  9. 1.2.7 Others
  10. 1.3 Aurora Kinase C Market by Application
  11. 1.3.1 Global Aurora Kinase C Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Non-Small Cell Lung Cancer
  13. 1.3.3 Acute Lymphocytic Leukemia
  14. 1.3.4 Solid Tumor
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Aurora Kinase C Market Dynamics
  1. 2.1 Aurora Kinase C Industry Trends
  2. 2.2 Aurora Kinase C Industry Drivers
  3. 2.3 Aurora Kinase C Industry Opportunities and Challenges
  4. 2.4 Aurora Kinase C Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Aurora Kinase C Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Aurora Kinase C Revenue by Region
  3. 3.2.1 Global Aurora Kinase C Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Aurora Kinase C Revenue by Region (2021-2026)
  5. 3.2.3 Global Aurora Kinase C Revenue by Region (2027-2032)
  6. 3.2.4 Global Aurora Kinase C Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Aurora Kinase C Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Aurora Kinase C Sales by Region
  9. 3.4.1 Global Aurora Kinase C Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Aurora Kinase C Sales by Region (2021-2026)
  11. 3.4.3 Global Aurora Kinase C Sales by Region (2027-2032)
  12. 3.4.4 Global Aurora Kinase C Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Aurora Kinase C Revenue by Manufacturers
  2. 4.1.1 Global Aurora Kinase C Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Aurora Kinase C Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Aurora Kinase C Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Aurora Kinase C Sales by Manufacturers
  6. 4.2.1 Global Aurora Kinase C Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Aurora Kinase C Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Aurora Kinase C Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Aurora Kinase C Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Aurora Kinase C Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Aurora Kinase C Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Aurora Kinase C Manufacturers, Product Type & Application
  13. 4.7 Global Aurora Kinase C Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Aurora Kinase C Market CR5 and HHI
  16. 4.8.2 2025 Aurora Kinase C Tier 1, Tier 2, and Tier 3
5 Aurora Kinase C Market by Type
  1. 5.1 Global Aurora Kinase C Revenue by Type
  2. 5.1.1 Global Aurora Kinase C Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Aurora Kinase C Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Aurora Kinase C Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Aurora Kinase C Sales by Type
  6. 5.2.1 Global Aurora Kinase C Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Aurora Kinase C Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Aurora Kinase C Sales Market Share by Type (2021-2032)
  9. 5.3 Global Aurora Kinase C Price by Type
6 Aurora Kinase C Market by Application
  1. 6.1 Global Aurora Kinase C Revenue by Application
  2. 6.1.1 Global Aurora Kinase C Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Aurora Kinase C Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Aurora Kinase C Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Aurora Kinase C Sales by Application
  6. 6.2.1 Global Aurora Kinase C Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Aurora Kinase C Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Aurora Kinase C Sales Market Share by Application (2021-2032)
  9. 6.3 Global Aurora Kinase C Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Aurora Kinase C Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Aurora Kinase C Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Amgen Inc
  8. 7.2.1 Amgen Inc Company Information
  9. 7.2.2 Amgen Inc Business Overview
  10. 7.2.3 Amgen Inc Aurora Kinase C Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Amgen Inc Aurora Kinase C Product Portfolio
  12. 7.2.5 Amgen Inc Recent Developments
  13. 7.3 AbbVie Inc
  14. 7.3.1 AbbVie Inc Company Information
  15. 7.3.2 AbbVie Inc Business Overview
  16. 7.3.3 AbbVie Inc Aurora Kinase C Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AbbVie Inc Aurora Kinase C Product Portfolio
  18. 7.3.5 AbbVie Inc Recent Developments
  19. 7.4 Cielo Therapeutics Inc
  20. 7.4.1 Cielo Therapeutics Inc Company Information
  21. 7.4.2 Cielo Therapeutics Inc Business Overview
  22. 7.4.3 Cielo Therapeutics Inc Aurora Kinase C Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Cielo Therapeutics Inc Aurora Kinase C Product Portfolio
  24. 7.4.5 Cielo Therapeutics Inc Recent Developments
8 North America
  1. 8.1 North America Aurora Kinase C Market Size by Type
  2. 8.1.1 North America Aurora Kinase C Revenue by Type (2021-2032)
  3. 8.1.2 North America Aurora Kinase C Sales by Type (2021-2032)
  4. 8.1.3 North America Aurora Kinase C Price by Type (2021-2032)
  5. 8.2 North America Aurora Kinase C Market Size by Application
  6. 8.2.1 North America Aurora Kinase C Revenue by Application (2021-2032)
  7. 8.2.2 North America Aurora Kinase C Sales by Application (2021-2032)
  8. 8.2.3 North America Aurora Kinase C Price by Application (2021-2032)
  9. 8.3 North America Aurora Kinase C Market Size by Country
  10. 8.3.1 North America Aurora Kinase C Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Aurora Kinase C Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Aurora Kinase C Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Aurora Kinase C Market Size by Type
  2. 9.1.1 Europe Aurora Kinase C Revenue by Type (2021-2032)
  3. 9.1.2 Europe Aurora Kinase C Sales by Type (2021-2032)
  4. 9.1.3 Europe Aurora Kinase C Price by Type (2021-2032)
  5. 9.2 Europe Aurora Kinase C Market Size by Application
  6. 9.2.1 Europe Aurora Kinase C Revenue by Application (2021-2032)
  7. 9.2.2 Europe Aurora Kinase C Sales by Application (2021-2032)
  8. 9.2.3 Europe Aurora Kinase C Price by Application (2021-2032)
  9. 9.3 Europe Aurora Kinase C Market Size by Country
  10. 9.3.1 Europe Aurora Kinase C Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Aurora Kinase C Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Aurora Kinase C Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Aurora Kinase C Market Size by Type
  2. 10.1.1 China Aurora Kinase C Revenue by Type (2021-2032)
  3. 10.1.2 China Aurora Kinase C Sales by Type (2021-2032)
  4. 10.1.3 China Aurora Kinase C Price by Type (2021-2032)
  5. 10.2 China Aurora Kinase C Market Size by Application
  6. 10.2.1 China Aurora Kinase C Revenue by Application (2021-2032)
  7. 10.2.2 China Aurora Kinase C Sales by Application (2021-2032)
  8. 10.2.3 China Aurora Kinase C Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Aurora Kinase C Market Size by Type
  2. 11.1.1 Asia Aurora Kinase C Revenue by Type (2021-2032)
  3. 11.1.2 Asia Aurora Kinase C Sales by Type (2021-2032)
  4. 11.1.3 Asia Aurora Kinase C Price by Type (2021-2032)
  5. 11.2 Asia Aurora Kinase C Market Size by Application
  6. 11.2.1 Asia Aurora Kinase C Revenue by Application (2021-2032)
  7. 11.2.2 Asia Aurora Kinase C Sales by Application (2021-2032)
  8. 11.2.3 Asia Aurora Kinase C Price by Application (2021-2032)
  9. 11.3 Asia Aurora Kinase C Market Size by Country
  10. 11.3.1 Asia Aurora Kinase C Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Aurora Kinase C Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Aurora Kinase C Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Aurora Kinase C Market Size by Type
  2. 12.1.1 SAMEA Aurora Kinase C Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Aurora Kinase C Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Aurora Kinase C Price by Type (2021-2032)
  5. 12.2 SAMEA Aurora Kinase C Market Size by Application
  6. 12.2.1 SAMEA Aurora Kinase C Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Aurora Kinase C Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Aurora Kinase C Price by Application (2021-2032)
  9. 12.3 SAMEA Aurora Kinase C Market Size by Country
  10. 12.3.1 SAMEA Aurora Kinase C Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Aurora Kinase C Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Aurora Kinase C Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Aurora Kinase C Value Chain Analysis
  2. 13.1.1 Aurora Kinase C Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Aurora Kinase C Production Mode & Process
  6. 13.2 Aurora Kinase C Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Aurora Kinase C Distributors
  9. 13.2.3 Aurora Kinase C Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst